Skip to main content
Recall Canary
Bisoprolol Fumarate and Hydrochlorothiazide Tablets 2.5 mg/6.25 mg
← Back to all recalls
DRUG RECALLMODERATE

Bisoprolol Fumarate and Hydrochlorothiazide Tablets 2.5 mg/6.25 mg

Unichem Pharmaceuticals recalls Bisoprolol/Hydrochlorothiazide 2.5/6.25 mg tablets (NDC 29300-187-01) due to N-Nitroso Bisoprolol impurity specification failure.

What to do

Do not use this medication. Contact your pharmacy or healthcare provider immediately for a replacement or alternative blood pressure medication. Return the recalled product to your pharmacy.

Posted
Updated
Recall No.
D-0301-2026
Agency
Firm
Unichem Pharmaceuticals USA Inc.
Recall ID
98323
Status
ONGOING

Why it was recalled

cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

How to identify it

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01

Where it was sold

Distributed nationwide.

Other recent recalls from Unichem Pharmaceuticals USA Inc.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification